In addition, most current studies demonstrated that SLC39A6, as an obligatory co-factor, has a crucial role in regulating epithelial–mesenchymal transition (EMT) in pancreatic [16] and prostate cancers [15], causing cancer cell migration. Here, SLC39A6 is linked to cancer.